Strata Skin Sciences, Inc.
SSKN
$1.42
-$0.05-3.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.27% | -2,414.14% | 27.79% | -18.53% | -96.01% |
| Total Depreciation and Amortization | -27.95% | -1.81% | -2.90% | -4.16% | -14.17% |
| Total Amortization of Deferred Charges | 2.56% | 0.00% | 25.81% | 39.29% | 34.48% |
| Total Other Non-Cash Items | -1,908.00% | 85.22% | -22.00% | 43.90% | -108.31% |
| Change in Net Operating Assets | 97.43% | -27.24% | -68.41% | -87.01% | 115.10% |
| Cash from Operations | 78.81% | -428.43% | 31.59% | -48.72% | 85.05% |
| Capital Expenditure | -1,541.94% | 117.68% | 72.55% | 70.66% | -131.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,541.94% | 117.68% | 72.55% | 70.66% | -131.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.82% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 12.82% | -- | -- | -- | 1,968.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.70% | -864.23% | 51.58% | 157.35% | 181.81% |